As genetic testing becomes more complex, the need for education continues to grow. Our webinar series, “Noninvasive Prenatal Testing: Background, Science, and Clinical Implementation,” was developed to help you propel progress in reproductive and genetic health. These modules are designed to be watched at your own pace. In this webinar, Dr Tina Ziainia, MD, FACOG, a Sharp-affiliated OB-GYN, provides insight and expertise on successfully implementing noninvasive prenatal testing (NIPT) into a busy practice. Having been in practice for over 17 years and having offered NIPT since 2013, she shares her personal experience. Noninvasive prenatal testing is a screening test. Results should be confirmed by diagnostic testing prior to making any pregnancy management decisions. View related webinars NIPT for All Pregnancies? A Discussion with Larry Platt, MD https://illuminainc.adobeconnect.com/_a1083004425/p23jpy1q68g Chromosomes, DNA, and Aneuploidy Syndromes | NIPT Webinar Series https://youtu.be/XU_Gfpak6fU Challenges of NIPT Discordance: Etiologies, Cases & Management | NIPT Webinar Series https://youtu.be/r4lc_FwLXXA Integrating Non-invasive DNA Testing (NIDT) into the Prenatal Testing Paradigm: Diana W. Bianchi, MD https://youtu.be/BWd9WNZ_3QM Subscribe to the Illumina video channel: http://www.youtube.com/subscription_center?add_user=IlluminaInc References Practice Bulletin No. 163: Screening for Fetal Aneuploidy. Obstet Gynecol. 2016;127(5):979-981. Benn P, Borrell A, Chiu RWK, et al. Position statement from the Chromosome Abnormality Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis. Prenat Diagn. 2015;35(8):725-734. doi:10.1002/pd.4608.